The Giving Block, a Shift4 company, is the platform helping nonprofits fundraise more effectively from modern philanthropists. Pioneers of the “Crypto Philanthropy” movement, The Giving Block developed the leading solutions for cryptocurrency donations, taking crypto and NFT donations mainstream in the nonprofit sector. The Giving Block’s team then developed a stock giving experience built to empower even more donors to give non-cash assets. When combined, The Giving Block’s product suite empowers more donors than ever to give assets to their favorite causes. Today, thousands of nonprofits are using The Giving Block to fundraise from modern philanthropists.
Status: Acquired
Digital Assets Data
Digital Assets Data is a financial technology and data company building enterprise-grade software and data feeds for crypto hedge funds, family offices, research firms, global consulting firms, banks, sovereigns, and other market participants. Digital Assets Data was acquired by NYDIG, a leading provider of investment and technology solutions for Bitcoin, in January 2021.
Bison Trails
Bison Trails is a blockchain infrastructure platform that was acquired by Coinbase in January 2021. The platform provides a suite of services, including: “Query & Transact”, enabling developers to more easily retrieve and analyze data generated from blockchain networks for trading, research or development purposes, and “Participate,” enabling companies to participate in a blockchains proof of stake (PoS) consensus mechanism and earn newly issued cryptocurrency rewards. These services are integrated into Coinbase Developer Platform and are offered through the Coinbase website.
SpectrumAi
SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize. SpectrumAi was acquired by CentralReach in 2025.
Invetx
Invetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a best-in-class, fully integrated biotechnology platform for the discovery, development, and manufacturing of veterinary monoclonal antibodies, and is developing a diverse product pipeline addressing chronic and severe diseases in the veterinary species. In July 2024, Invetx was acquired by Dechra Pharmaceuticals Limited (Dechra), a global specialist veterinary pharmaceuticals business.
Blue Rabbit
Blue Rabbit is a chronic disease management platform designed to coordinate diagnostics, medications and nutrition for animal patients. The company enables the effortless administration of healthcare through an ecosystem of technology driven solutions and services.
Arion Cancer Hospital
The company specializes in personalized full-cycle cancer treatments and management, from prevention and early test of symptoms to the adoption of advanced cancer treatment methods.
Verve Therapeutics
Verve Therapeutics (NASDAQ: VERV) is a biotechnology company created with a singular focus: to protect the world from heart disease. Verve is developing therapies to safely edit the genome of adults and confer lifelong protection from coronary artery disease, the most common form of heart disease and the leading cause of death worldwide. Verve was acquired by Eli Lilly in 2025.
Arvelle Therapeutics
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders. Arvelle is responsible for the development and commercialization of cenobamate, an investigational antiepileptic drug, in the European market. Arvelle Therapeutics was acquired by Angelini Pharma in January 2021.
RiskLens
RiskLens is the leading provider of quantitative cyber risk management software. Its platform is recognized as a mission-critical business application for cybersecurity and risk teams across the Fortune 1,000. RiskLens empowers large enterprises and government organizations to manage cyber risk from the business perspective by quantifying that risk in monetary terms. Clients depend on RiskLens solutions to better understand and communicate their cyber risk exposure in financial terms, prioritize their risk mitigations, measure the ROI of their security investments, and meet regulatory demands calling for the quantification of cyber risk. RiskLens is the only cyber risk quantification software purpose-built on FAIR, the standard quantification model for information security and operational risk. RiskLens was acquired by Safe Security in 2023.